News

Explore the concept of interdependence in politics and psychiatry, emphasizing connection and cooperation to enhance mental health and societal well-being.

Government funding cuts to mental health and addiction programs create chaos, prompting swift restoration amid widespread concern from advocacy groups. Read the statement from the AFSP here.

In this CME article, explore the groundbreaking role of muscarinic cholinergic receptors in schizophrenia treatment, highlighting innovative therapies like KarXT for improved patient outcomes.

Artificial intelligence revolutionizes sports, enhancing performance and officiating, while raising concerns about the human element of competition.

Explore the multifaceted role of time in psychotherapy, from patient dynamics to treatment duration, and its impact on healing and growth.

LPCN 1154 shows promise as a rapid, at-home treatment for postpartum depression, with favorable safety results in ongoing phase 3 trials.

Exploring the vital link between nutrition and mental health, this article highlights dietary strategies to enhance psychiatric well-being and cognitive function.

Inpatient psychiatry faces an epidemic of violence, highlighting systemic neglect and the urgent need for reform to protect health care workers.

Explore the evolving landscape of psychiatry as it reflects on past events, current challenges, and future predictions for mental health.

BioXcel Therapeutics submits an sNDA to the FDA for Igalmi to treat agitation in bipolar disorder and schizophrenia at home.

Explore how lifestyle psychiatry transforms depression treatment through nutrition, exercise, sleep, and social connections for holistic recovery and resilience.

Eating disorders pose a significant risk to athletes' health, highlighting the urgent need for awareness, support, and compassionate change in sports culture.

Researchers discuss precision medicine's potential to enhance opioid use disorder treatment.

Reflecting on Martin Luther King Jr.'s legacy, the article explores his insights on mental health, social justice, and the need for unity today.

Review the misperceptions patients and clinicians may have about ADHD diagnosis and treatment.

Experts discuss the complex relationship between ADHD treatment and substance use disorder.

Barry Herman, MD, shares insights on real-world data of online ADHD assessment tool and telepsychiatry.

Clinicians explore the complex relationship between ADHD medication and pregnancy, emphasizing individualized risk assessments for optimal maternal and child health.

A groundbreaking online ADHD assessment shows 78% agreement with clinician evaluations, enhancing access to mental health care for adults.

Seltorexant shows promise as a safe adjunctive treatment for patients with major depressive disorder and insomnia symptoms, with fewer weight changes than quetiapine XR.

Explore key insights on ADHD treatment barriers and the long-term outcomes for adolescents diagnosed with the disorder.

Explore the emerging role of lifestyle interventions in psychiatry, enhancing patient care through nutrition and physical activity for mental health.

New research reveals midlife ADHD patients exhibit early Alzheimer disease biomarkers.

New data reveals Caplyta significantly improves remission rates in adults with major depressive disorder, offering hope for lasting relief from symptoms.

Centanafadine demonstrates promising effects on ADHD symptoms, enhancing key neurotransmitters without increasing psychomotor activity, according to poster data.

Axsome Therapeutics begins a pivotal trial for AXS-14, aiming to improve fibromyalgia management and address significant patient needs.

Innovative combinations of transcranial magnetic stimulation and ketamine therapy offer new hope for treatment-resistant depression, pain, and substance use disorders.

A clinician shares her journey as a 3-time suicide survivor, advocating for vulnerability and compassion in mental health care.

New data reveals valbenazine (Ingrezza) shows significantly higher VMAT2 target occupancy than deutetrabenazine (Austedo XR).

Psychiatrists explore the mental health impacts of protests, emphasizing the need for community support and ethical responsibility in turbulent times.